ecrin-mdr-crcClinical2007Unresectable advanced/recurrent colorectal cancerUnresectable Advanced/recurrent Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2616834Japan8ECRIN MDRCompletedfalsePhase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimenInterventions: Irinotecan+S-1, repeated every 3 weeks. Primary outcome(s): RR Study Design: Single arm Non-randomized2007-08-152616834JPRN-UMIN000001342